Stock Split History
ETFs Holding STAA »    STAA Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. Co. is a manufacturer of lenses used worldwide in corrective or refractive surgery. Co.'s principal products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of Co.'s ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts. According to our Staar Surgical stock split history records, Staar Surgical has had 1 split.
Staar Surgical stock split history picture
Staar Surgical (STAA) has 1 split in our Staar Surgical stock split history database. The split for STAA took place on May 18, 1992. This was a 1 for 2 reverse split, meaning for each 2 shares of STAA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split.

When a company such as Staar Surgical conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Staar Surgical stock split history from start to finish, an original position size of 1000 shares would have turned into 500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Staar Surgical shares, starting with a $10,000 purchase of STAA, presented on a split-history-adjusted basis factoring in the complete Staar Surgical stock split history. Staar Surgical split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/18/2011
End date: 05/17/2021
Start price/share: $5.53
End price/share: $113.92
Dividends collected/share: $0.00
Total return: 1,960.04%
Average Annual Total Return: 35.31%
Starting investment: $10,000.00
Ending investment: $206,071.80
Years: 10.01
Date Ratio
05/18/19921 for 2
STAA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

STE Split History
STEM Split History
STJ Split History
STXS Split History
SURG Split History
SYBX Split History
SYK Split History
SYN Split History
TARO Split History
TBRA Split History

Also explore: STAA shares outstanding history

LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Staar Surgical
Staar Surgical Insider Buying

Staar Surgical Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.